Locus Biosciences today announced a contract award from the National Institute of Allergy and Infectious Diseases (NIAID), ...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has ...

In a recent review published in Cell, researchers presented an overview of bacteriophage treatment, including mechanisms, types, design and applications of bacteriophage therapy. Study: Phage therapy: ...

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial ...

We found that this bacteriophage has different fibrils—or 'legs'—and receptors on them that recognize bacteria," added Oksana Kotovskaya, a co-author of the work and a Ph.D. student of the Life ...

Tuberculosis (TB) is a fatal infectious disease that caused 1.5 million deaths worldwide in 2020. Developing countries are particularly affected and diagnosis, especially in children and adolescents, ...

The lytic and lysogenic cycles are the two main phases of a virus’ infective lifecycle and route to replication. The lytic cycle, or virulent infection, involves a virus taking control of a host cell ...

Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria Locus Biosciences today announced a ...